Skip to content
TimeLinq

Asset comparator

Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.

  • Sysmex Corporation
  • Eli Lilly

Rentabilidad comparada (base 100)

Cada activo vale 100 el 13 de octubre de 2025; un valor de 120 significa +20 % desde esa fecha (última fecha común: 9 de octubre de 2026).

Indicadores

«N/A» indica un indicador que no tiene sentido para este tipo de activo: no debe compararse.

IndicadorSysmex CorporationStockEli LillyStock
Rentabilidad y riesgo
Performance over the periodChange in price between the first and last common dates.−3.8%+43.9%
Annualized performanceAverage annual return that would produce the same total performance.−3.9%+44.5%
Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates.39.8%34.6%
Maximum DrawdownLargest decline from peak to subsequent trough over the period.−33.6%−23.3%
Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period.-0.031.39
1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR).−4.0%−2.7%
Fundamentales
Market capitalizationTotal market value of all shares (or circulating tokens for a crypto).7.11B $1.05T $
P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid.28.739.6
Price-to-SalesMarket capitalization divided by annual revenue.0.013.2
Net marginShare of revenue retained as profit.7.5%33.5%
Return on equityReturn on equity (ROE).8.3%102.3%
Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year.+23.6%+47.7%
Dividend yieldAnnual dividend relative to the share price.2.02%0.59%
Debt / equityFinancial debt relative to shareholders' equity.25%162%

Correlaciones en el periodo

De −1 a 1: cerca de 1, los dos activos suben y bajan juntos; cerca de 0, evolucionan de forma independiente.

  • Sysmex Corporation / Eli Lilly0,16

Análisis comparativo

Análisis generado por IA

La IA compara los activos seleccionados solo a partir de las cifras anteriores, señalando lo que no es comparable. El texto solo se genera a petición suya.

Información facilitada con fines pedagógicos. No constituye asesoramiento en inversiones ni una recomendación personalizada. Las rentabilidades pasadas no garantizan las rentabilidades futuras.